Serum globulin in myasthenia gravis: Inhibition of α-bungarotoxin binding to acetylcholine receptors

Richard R. Almon, Clifford G. Andrew, Stanley H. Appel

Research output: Contribution to journalArticlepeer-review

Abstract

Serum factors that inhibit the binding of 125I-labeled α-bungarotoxin to the acetylcholine receptor extracted in detergent from denervated rat muscle were detected by a sensitive assay. The serum of at least 5 and possibly 11 out of 15 patients with myasthenia gravis showed inhibitory activity that was localized to the globulin fraction. No controls showed inhibitory activity. The demonstration of inhibitory globulins may help explain the involvement of the immune system in the pathophysiology of the neuromuscular junction in patients with myasthenia gravis.

Original languageEnglish (US)
Pages (from-to)55-57
Number of pages3
JournalScience
Volume186
Issue number4158
DOIs
StatePublished - Jan 1 1974
Externally publishedYes

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Serum globulin in myasthenia gravis: Inhibition of α-bungarotoxin binding to acetylcholine receptors'. Together they form a unique fingerprint.

Cite this